Dyspareunia in postmenopausal women: A critical review

Pain Research and Management

Volumn 13, Issue 3, 2008, Pages 243-254

  Kao, Alina ^a   Binik, Yitzchak M ^a,b   Kapuscinski, Anita ^a   Khalifé, Samir ^c  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Dyspareunia; Estrogen; Hormone replacement therapy; Menopause; Pain; Postmenopausal women; Sexual

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ETHINYLESTRADIOL; LEVONORGESTREL; PLACEBO; POLYCARBOPHIL; PROGESTERONE; TIBOLONE;

AGING; ANALGESIA; CAUSAL ATTRIBUTION; CLIMACTERIUM; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DYSPAREUNIA; ENDOCRINE DISEASE; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE SEXUAL DYSFUNCTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; PATIENT ATTITUDE; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; REVIEW; SEX THERAPY; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VAGINA ATROPHY;

EID: 49249090673     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/269571     Document Type: Review

References (96)

1. Easley, ED. Sex problems after the menopause. Clin Obstet Gynecol 1978;21:269-77.
2. Studd JWW, Watson NR, Henderson A. Symptoms and metabolic sequelae of the menopause. In: Drife JO, Studd JWW, eds. HRT and Osteoporosis. London: Springer Verlag, 1990:23-34.
3. Meana M, Binik YM, Khalifé S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997;90:583-9.
4. Channon LD, Ballinger SE. Some aspects of sexuality and vaginal symptoms during the menopause and their relation to anxiety and depression. Br J Med Psychol 1986;59:173-80.
5. Bachmann G. The estriadol vaginal ring - a study of existing clinical data. Maturitas 1995;22(Suppl):S21-9.
6. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772-80.
7. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005;2(Suppl 3):154-65.
8. Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997;314:228-31.
9. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75(4 Suppl):26S-30S.
10. Hagstad A. Gynecology and sexuality in middle-aged women. Women Health 1988;13:57-80.
11. Osborn M, Hawton K, Gath D. Sexual dysfunction among middle aged women in the community. Br Med J (Clin Res Ed) 1988;296:959-62.
12. Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425-7.
13. Laumann EO, Gagnon JH, Michael RT, Michaels S. The Social Organization of Sexuality: Sexual Practices in the United States. Chicago: University of Chicago Press, 1994.
14. Najman JM, Dunne MP, Boyle FM, Cook MD, Purdie DM. Sexual dysfunction in the Australian population. Aust Fam Physician 2003;32:951-4.
15. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C; Global Study of Sexual Attitudes and Behaviors Investigators' Group. Sexual behavior and sexual dysfunctions after age 40: The global study of sexual attitudes and behaviors. Urology 2004;64:991-7.
16. World Health Organization Scientific Group. Research on the menopause. World Health Organ Tech Rep Ser 1981;670:1-120.
17. Sukwatana P, Meekhangvan J, Tamrongterakul T, Tanapar Y, Asavarait S, Boonjitrpimon P. Menopausal symptoms among Thai women in Bangkok. Maturitas 1991;13:217-28.
18. Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Maturitas 1992;15:101-11.
19. Líndal E, Stefànsson JG. The lifetime prevalence of psychosexual dysfunction among 55- to 57-year-olds in Iceland. Soc Psychiatry Psychiatr Epidemiol 1993;28:91-5.
20. Sarrel PM, Whitehead MI. Sex and menopause: Defining the issues. Maturitas 1985;7:217-24.
21. Dhillon HK, Singh HJ, Ghaffar NA. Sexual function in menopausal women in Kelantan, Malaysia. Maturitas 2005;52:256-63.
22. Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynecol 1997;104:87-91.
23. Barlow DH, Samsioe G, van Geelen JM. A study of European womens' experience of the problems of urogenital ageing and its management. Maturitas 1997;27:239-47.
24. Borissova AM, Kovatcheva R, Shinkov A, Vukov M. A study of the psychological status and sexuality in middle-aged Bulgarian women: Significance of the hormone replacement therapy (HRT). Maturitas 2001;39:177-83.
25. Ballinger SE. Psychosocial stress and symptoms of menopause: A comparative study of menopause clinic patients and non-patients. Maturitas 1985;7:315-27.
26. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19:171-88.
27. Versi E, Harvey MA, Cardozo L, Brincat M, Studd JW. Urogenital prolapse and atrophy at menopause: A prevalence study. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:107-10.
28. Flory N, Bissonnette F, Binik YM. Psychosocial effects of hysterectomy: Literature review. J Psychosom Res 2005;59:117-29.
29. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999;282:1934-41.
30. Zussman L, Zussman S, Sunley R, Bjornson E. Sexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis. Am J Obstet Gynecol 1981;140:725-9.
31. Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: A comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:171-6.
32. Simunic V, Banovic I, Ciglar S, Jeren L, Pavicic Baldani D, Sprem M. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003;82:187-97.
33. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277-99.
34. McCoy NL. The McCoy Female Sexuality Questionnaire. Qual Life Res 2000;9(Suppl 1):739-45.
35. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
36. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-60.
37. Berg G, Gottwall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986. Maturitas 1988;10:193-9.
38. Moore B, Kombe H. Climacteric symptoms in a Tanzanian community. Maturitas 1991;13:229-34.
39. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997;26:83-93.
40. van Geelen JM, van de Weijer PH, Arnolds HT. Urogenital symptoms and the resulting discomfort in non-institutionalized Dutch women aged 50-75 years. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:9-14.
41. Maartens LW, Leusink GL, Knottnerus JA, Smeets CG, Pop VJ. Climacteric complaints in the community. Fam Pract 2001;18:189-94.
42. Cain VS, Johannes GB, Avis NE, et al. Sexual functioning and practices in a multi-ethnic study of midlife women: Baseline results from SWAN. J Sex Res 2003;40:266-76.
43. Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand 2005;84:72-8.
44. Meana M, Binik YM, Khalifé S, Cohen D. Dyspareunia: Sexual dysfunction or pain syndrome? J Nerv Ment Dis 1997;185:561-9.
45. Merskey H, Bogduk N, eds. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd edn. Washington: IASP Press, 1994.
46. Moyal-Barracco M, Lynch PJ. 2003 ISSVD terminology and classification of vulvodynia: A historical perspective. J Reprod Med 2004;49:772-7.
47. Binik YM, Meana M, Berkley K, Khalifé S. The sexual pain disorders: Is the pain sexual or is the sex painful? Annu Rev Sex Res 1999;10:210-35.
48. Harlow BL, Wise LA, Stewart ED. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001;185:545-50.
49. Kao A, Binik YM, Khalifé S, Amsel R. Vulvar vestibulitis syndrome after menopause? If the criteria fit... Poster presentation, 33rd annual meeting of the International Academy of Sex Research. Vancouver, 2007.
50. Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 2005;40:1258-62.
51. Payne KA, Binik YM, Amsel R, Khalifé S. When sex hurts, anxiety and fear orient attention towards pain. Eur J Pain 2005;9:427-36.
52. Basson R. Recent advances in women's sexual function and dysfunction. Menopause 2004;11:714-25.
53. Oldenhave A. Some aspects of sexuality during the normal climacteric. In: Berg G, Hammer M, eds. The Modern Management of the Menopause: A Perspective for the 21st Century. London: Parthenon, 1994:605-15.
54. Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: A review of population-based studies. J Sex Med 2005;2:317-30.
55. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
56. Weber AM, Walters MD, Schovet LR, Mitchinson A. Vaginal anatomy and sexual function. Obstet Gynecol 1995;86:946-9.
57. Mishra G, Kuh D. Sexual functioning throughout menopause: The perceptions of women in a British cohort. Menopause 2006;13:880-90.
58. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456-60.
59. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005;84:174-80.
60. Avis NE, Stellato R, Crawford S, Johannes C, Longcope C. Is there an association between menopause status and sexual functioning? Menopause 2000;7:297-309.
61. James CE, Breeson AJ, Kovacs G, et al. The symptomatology of the climacteric in relation to hormonal and cytological factors. Br J Obstet Gynaecol 1984;91:56-62.
62. Cutler WB, Garcia CR, McCoy N. Perimenopausal sexuality. Arch Sex Behav 1987;16:225-34.
63. Laan E, van Lunsen RH. Hormones and sexuality in postmenopausal women: A psychophysiological study. J Psychosom Obstet Gynaecol 1997;18:126-33.
64. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: A literature review. Menopause 2004;11:120-30.
65. Gürel H, Gürel SA. Pelvic relaxation and associated risk factors: The results of logistic regression analysis. Acta Obstet Gynecol Scand 1999;78:290-3.
66. Reay Jones NH, Healy JC, King LJ, Saini S, Shousha S, Allen-Mersh TG. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg 2003;90:466-72.
67. Rosenbaum TY. Managing postmenopausal dyspareunia: Beyond hormone therapy. (Version current at May 29, 2008).
68. Goldstein I. Current management strategies of the postmenopausal patient with sexual health problems. J Sex Med 2007;4(Suppl 3):235-53.
69. Reissing ED, Brown C, Lord MJ, Binik YM, Khalifé S. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol 2005;26:107-13.
70. Johnston SL, Farrell SA, Bouchard C, et al; SOGC Joint Committee-Clinical Practice Gynaecology and Urogynaecology. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26:503-15.
71. Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996;23:259-63.
72. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med 2000:9(Suppl 1):S25-32.
73. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355-69.
74. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;(4):CD001500.
75. Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 1990;70:1124-31.
76. Nathorst-Böös J, Wiklund I, Mattsson L-A, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656-60.
77. Morris EP, Wilson POG, Robinson J, Rymer JM. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynaecol 1999;106:954-9.
78. Castelo-Branco C, Vicente JJ, Figueras F, et al. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas 2000;34:161-8.
79. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: Effects on sexuality and well-being. Climacteric 2002;5:357-65.
80. Fonseca AM, Bagnoli VR, Penteado SR, Paixão JS, Cavalcanti AL, Pinotti JA. Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women. Clin Drug Investig 2007;27:131-7.
81. Eriksen PS, Rasmussen H. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: A double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 1992;44:137-44.
82. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624-32.
83. Ayton RA, Darling GM, Murkies AL, et al. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351-8.
84. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73-80.
85. Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 2000;107:1029-34.
86. Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006;13:737-43.
87. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual functioning: A review of double-blind, randomized controlled trials. Menopause 2004;11:749-65.
88. Ballagh SA. Vaginal hormone therapy for urogenital and menopausal symptoms. Semin Reprod Med 2005;23:126-40.
89. Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 1983;249:2195-8.
90. Semmens JP, Tsai CC, Semmens EC, Loadholt CB. Effects of estrogen therapy on vaginal physiology during menopause. Obstet Gynecol 1985;66:15-8.
91. Pukall CF, Reissing ED, Binik YM, Khalifé S, Abbott FV. New clinical and research perspectives on the sexual pain disorders. J Sex Educ Ther 2000;25:36-44.
92. Reissing ED, Binik YM, Khalifé S, Cohen D, Amsel R. Etiological correlates of vaginismus: Sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment. J Sex Marital Ther 2003;29:47-59.
93. Bergeron S, Binik YM, Khalifé S, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306.
94. Castelo-Branco C, Palacios S, Mostajo D, Tobar C, von Helde S. Menopausal transition in Movima women, a Bolivian Native-American. Maturitas 2005;51:380-5.
95. Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: A comparative study. Clin Pharmacol Ther 1998;64:204-10.
96. Dugal R, Hesla K, Sørdal T, Aase KH, Lilleeidet O, Wickstrøm E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-7.